GlassScriptPhysician profile
Patrick J Guthrie
NPI 1063855138
$5,035.34
in general payments reported to CMS, 2019-2025
34 companies · $976 in 2025
The $976 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,004 · 2020: $204 · 2021: $477 · 2022: $360 · 2023: $559 · 2024: $454 · 2025: $976.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,989.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,989.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,059.06 | 2019-2023 | Rezum Generator |
| Coloplast Corp | $802.97 | 2019-2025 | |
| Astellas Pharma US INC | $473.49 | 2019-2024 | Xtandi |
| Teleflex LLC | $316.79 | 2023-2025 | Barrigel, Urolift |
| Myriad Genetic Laboratories, INC. | $239.38 | 2020-2024 | Precisetumor, Prolaris, Myrisk |
| Endo Pharmaceuticals INC. | $239.35 | 2019-2023 | Xiaflex, Aveed |
| Endo USA, INC. | $216.32 | 2024-2025 | Xiaflex, Aveed |
| Procept Biorobotics Corporation | $185.34 | 2025 | |
| Calyxo, INC. | $173.62 | 2025 | Cvac Aspiration System |
| Abbvie INC. | $153.23 | 2022-2025 | |
| Baxter Healthcare | $145.26 | 2025 | Tisseel |
| Urovant Sciences INC | $134.87 | 2021-2022 | |
| Olympus America INC. | $126.31 | 2019-2025 | Itind System |
| Sumitomo Pharma America, INC. | $110.31 | 2023-2024 | Orgovyx, Gemtesa |
| Antares Pharma, INC. | $73.26 | 2019-2024 | Xyosted |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $70.83 | 2023 | Erleada |
| Novartis Pharmaceuticals Corporation | $61.38 | 2024-2025 | |
| Hollister Incorporated | $49.96 | 2022-2023 | Vapro |
| Urogen Pharma, INC. | $44.40 | 2021-2023 | Jelmyto |
| Myovant Sciences INC. | $43.22 | 2021 | |
| Pfizer INC. | $36.93 | 2019-2021 | |
| Axonics, INC. | $30.25 | 2023-2024 | Bulkamid, Axonics |
| Intuitive Surgical, INC. | $29.41 | 2025 | |
| Allergan, INC. | $28.13 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $25.69 | 2021 | |
| 180 Medical, INC. | $23.54 | 2021 | |
| Merck Sharp & Dohme LLC | $20.30 | 2024 | Bridion |
| Bayer Healthcare Pharmaceuticals INC. | $19.76 | 2020 | |
| Travere Therapeutics, INC. | $19.62 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $18.47 | 2023 | Lynparza |
| Zyla Life Sciences, INC. | $17.71 | 2020 | |
| Rochester Medical Corporation | $16.53 | 2021 | |
| Foundation Medicine, INC. | $14.89 | 2020 | |
| Progenics Pharmaceuticals, INC. | $14.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Guthrie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.